Work

Serum p24 Antigen Level as an Intermediate End Point in Clinical Trials of Zidovudine in People Infected with Human Immunodeficiency Virus Type 1

Year: 1994

Type: article

Source: The Journal of Infectious Diseases

DOI: 10.1093/infdis/169.4.713

Authors: V. DeGruttola, L. A. Beckett, R. W. Coombs, J. M. Arduino, H. H. Balfour, S. Rasheed, F. B. Hollinger, M. A. Fischl, P. Volberding

Institution: Harvard University

Language: English

Topic: HIV Research and Treatment

Subfield: Virology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Institute of Allergy and Infectious Diseases

Awards: G1391438511, STATISTICAL AND DATA ANALYSIS CENTER, G2290577323, G3121146267, STATISTICAL MODELING OF PROGRESSION OF HIV INFECTION

OpenAlex ID: W2314098905

FWCI: 2.523

Cites: 12

Cited by: 28

Related to: 10